Artemis Medicare Services Ltd
Artemis Medicare Services Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #14 of 33 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Sustained year-on-year volume growth expected, supported by hiring new doctors and strengthening international business. Artemis Medicare expects sustained volume growth supported by new doctor hires and focus on international business.
From Artemis Medicare Services Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Sustained year-on-year volume growth expected, supported by hiring new doctors and strengthening international business.
- Flagship Gurugram facility shows robust growth with rising international patient revenue (32% of total) and capacity expansion (new operation theatres, specialized units).
- Raipur 300-bed facility set to commission by end of FY26; targeting break-even in 1 to 1.5 years with conservative occupancy ramp-up (40-50% initially).
- South Delhi 650-bed project underway; expected operational in 1.5 to 2 years post contract signing by December 2025.
- Expansion of beds at Gurgaon planned: adding 100 beds after reaching 70% occupancy, and potentially further 200 beds by acquiring additional FAR.
2 more points from Artemis Medicare Services Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Artemis Medicare Services Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Capex is planned for aggressive bed expansion over next 2-3 years, including:
- 100 bed expansion at Gurgaon at INR 70-75 lakhs per bed.
- Raipur facility investment: INR 100-110 crores, with operating losses estimated at INR 15-18 crores until breakeven.
- South Delhi 650-bed facility under binding MoU; details on capex and funding to be disclosed post contract finalization expected by end of December 2025.
- Peak debt for capex and funding to not exceed INR 350 crores; internal accruals and external funding options (e.g., QIP, IFC funding) are planned.
- Expansion funded from a mix of internal accruals, debt, and possible equity.
- The company aims to maintain debt-to-equity and financial covenants while expanding.
2 more points from Artemis Medicare Services Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Artemis Medicare Services Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Artemis Medicare Services Ltd's call on order book
Create a free account to keep reading this call
Artemis Medicare Services Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹306 Cr, net profit ₹31 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Artemis Medicare Services Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Maitreya Medica. (Q2 FY26)
23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medicare's Q2 FY26 investor presentation — and how it ranks against sector peers.
- Metropolis Healt (Q2 FY26)
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
- 3B Blackbio DX Ltd (Q2 FY26)
Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…
- Unihealth Hospitals Ltd (Q2 FY26)
Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India). Key concall takeaways from Unihealth Hospitals Ltd's Q2 FY26…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Artemis Medicare Services Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Artemis Medicare Services Ltd Q2 FY26 results?
Sustained year-on-year volume growth expected, supported by hiring new doctors and strengthening international business. Artemis Medicare expects sustained volume growth supported by new doctor hires and focus on international business.
What is Artemis Medicare Services Ltd share price analysis?
Artemis Medicare Services Ltd currently shows a neutral. The stock trades at a P/E of 42.0 with a market cap of ₹4,850 Cr. Investors should review the full earnings analysis for detailed insights.
Is Artemis Medicare Services Ltd planning capital expenditure?
Capex is planned for aggressive bed expansion over next 2-3 years, including: - 100 bed expansion at Gurgaon at INR 70-75 lakhs per bed.
Keep Artemis Medicare Services Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.